Pharmacy And Poisons Board, Kemsa To Mop Up Recalled ARVs

The Pharmacy and Poisons Board is partnering with Kemsa to ensure that all recalled ARV stocks are cleaned up and returned to a central location.

The entities are coordinating the reverse logistics of all quarantined stocks with the manufacturer.

In a statement issued on Friday, the PPB assured the public that adequate safeguards have been put in place to ensure that medicines supplied to the Kenyan market meet the required quality, safety, and efficacy standards.

The Ministry of Health advised patients on Wednesday to return the ARVs they had received in exchange for others from other manufacturers, despite assurances that there would be enough stock.

This followed a two-week recall of ARVs supplied by Universal Corporation due to faulty packaging and black spots on some tablets.

“The PPB has collected several samples from healthcare facilities and they have been submitted to the Quality Control Laboratory for further analysis,” the statement read in part.

“All healthcare facilities are instructed to quarantine all stocks of the product and accept the products returned by clients,” it added.

After the manufacturer discovered that improper packaging had stained a few tablets, the Pharmacy and Poisons Board ordered a recall of 14 batches containing thousands of tablets.

On November 8, Pharmacy and Poisons Board CEO Dr. Fred Siyoi issued the recall after receiving complaints about discolored induction seals on some bottles containing a few tablets with unusual black spots.

“We encourage the public to be vigilant at all times and report any suspected poor-quality medicines or adverse drug reactions to the nearest healthcare facility and the PPB,” Siyoi said.